Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Study of Sitagliptin, Pioglitazone, and Dapagliflozin in Diabetic Rats with MI
NCT07083232Phase 4Completed
- Sponsor
- Al-Azhar University
- Start
- Oct 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin, pioglitazone, dapagliflozin in myocardial infarction (MI), sponsored by Al-Azhar University. Started Oct 2024; status: completed.
02
Drugs
sitagliptinpioglitazonedapagliflozin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT07083232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07083232.